Development of an Assay for Methotrexate and Its Metabolites 7-Hydroxy Methotrexate and DAMPA in Serum by LC-MS/MS
Methotrexate (MTX) is a folic acid antagonist that is widely used as an immunosuppressant and chemotherapeutic agent. After high-dose administration of MTX serum levels must be monitored to determine when to administer leucovorin, a folic acid analog that bypasses the enzyme inhibition caused by MTX and reverses its toxicity. We describe a rapid and simple turbulent flow liquid chromatography (TFLC) method implementing positive heated electrospray ionization (HESI) for the accurate and precise determination of MTX, 7-hydroxymethotrexate (7-OH MTX), and 4-amino-4-deoxy-N10-methylpteroic acid (DAMPA) concentrations in serum. MTX is isolated from serum samples (100 μL) after protein precipitation with a methanolic solution containing internal standard (MTX-D3) followed by centrifugation. The supernatant is injected into the turbulent flow liquid chromatography which is followed by electrospray positive ionization tandem mass spectrometry (TFLC-ESI-MS/MS) and quantified using a six-point calibration curve. For MTX, 7-OH MTX, and DAMPA the assays were linear from 20 to 1000 nmol/L. Dilutions of 10-, 100-, and 1000-fold were validated giving a clinically reportable range of 20 to1.0 × 106 nmol/L. Within-day and between-day precisions at concentrations spanning the analytical measurement ranges were less than 10 % for all three analytes.
Key wordsMethotrexate Carboxypeptidase-G2 Therapeutic drug monitoring Mass spectrometry Turbulent flow liquid chromatography
- 1.LaCasce AS (2014) Therapeutic use and toxicity of high-dose methotrexate. In: Post TW (ed) UpToDate. Waltham, MA. Accessed 1 Oct 2014Google Scholar
- 4.DeAngellis LM, Tong WP, Lin S, Fleisher M et al (1996) Carboxypeptidase G2 rescue after high-dose methotrexate. J Clin Oncol 14:2145–2149Google Scholar
- 7.Kumar VS, Law T, Kellogg M (2010) Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for monitoring methotrexate in the setting of carboxypeptidase-G2 therapy. In: Garg U, Hammett-Stabler CA (eds) Clinical applications of mass spectrometry: methods in molecular biology 603. Humana Press, New YorkGoogle Scholar